A new duplex qPCR assay shows high sensitivity for detecting staphylococcus aureus in clinical samples, indicating improved diagnostics over traditional methods.
(1) Background: Staphylococcus aureus is a common human respiratory pathogen. Its widespread antimicrobial resistance often leads to severe infections. However, the high genomic diversity among strains frequently causes false negatives in conventional PCR assays. (2) Methods: To address this limitation, we developed a highly sensitive and specific duplex fluorescent quantitative PCR (qPCR) method for S. aureus detection based on pangenome analysis. Conserved core genome sequences of S. aureus were identified using a pangenomic approach. Two highly conserved and species-specific genes—isdA and recQ—were selected as target loci for the duplex qPCR assay. A TaqMan probe-based duplex fluorescent qPCR assay was established, enabling simultaneous detection of both isdA and recQ genes in a single reaction. (3) Results: The assay demonstrated detection sensitivities of 1.335 × 103 copies/μL for isdA and 7.265 × 102 copies/μL for recQ. The intra-assay and inter-assay coefficients of variation (CV) for Ct values were below 1.86% and 2.87%, respectively, indicating excellent reproducibility. Specificity analysis revealed no cross-reactivity with genomic DNA from 14 common respiratory pathogens, including Pseudomonas aeruginosa and Streptococcus pneumoniae. (4) Conclusions: Due to its high specificity and sensitivity, this duplex qPCR assay effectively overcomes limitations of single-target PCR methods, such as missed detections and prolonged turnaround times, and holds significant potential for practical diagnostic applications.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: